| Literature DB >> 35164121 |
Yinyue Wang1, Mai Wang1, Feier Lin1, Xinyan Zhang1, Yongming Zhao1, Chunyan Guo1,2, Jin Wang1,2.
Abstract
Due to the remarkable anti-tumor activities of oridonin (Ori), research on Rabdosia rubescens has attracted more and more attention in the pharmaceutical field. The purpose of this study was to extract Ori from R. rubescens by ultrasound-assisted extraction (UAE) and prepare Ori liposomes as a novel delivery system to improve the bioavailability and biocompatibility. Response surface methodology (RSM), namely Box-Behnken design (BBD), was applied to optimize extraction conditions, formulation, and preparation process. The results demonstrated that the optimal extraction conditions were an ethanol concentration of 75.9%, an extraction time of 35.7 min, and a solid/liquid ratio of 1:32.6. Under these optimal conditions, the extraction yield of Ori was 4.23 mg/g, which was well matched with the predicted value (4.28 mg/g). The optimal preparation conditions of Ori liposomes by RSM, with an ultrasonic time of 41.1 min, a soybean phospholipids/drug ratio of 9.6 g/g, and a water bath temperature of 53.4 °C, had higher encapsulation efficiency (84.1%). The characterization studies indicated that Ori liposomes had well-dispersible spherical shapes and uniform sizes with a particle size of 137.7 nm, a polydispersity index (PDI) of 0.216, and zeta potential of -24.0 mV. In addition, Ori liposomes presented better activity than free Ori. Therefore, the results indicated that Ori liposomes could enhance the bioactivity of Ori, being proposed as a promising vehicle for drug delivery.Entities:
Keywords: Rabdosia rubescens; liposomes; oridonin; ultrasound-assisted extraction
Mesh:
Substances:
Year: 2022 PMID: 35164121 PMCID: PMC8839758 DOI: 10.3390/molecules27030860
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Levels of factors for the UAE.
| Independent Variables | Code | −1 | 0 | 1 |
|---|---|---|---|---|
| Ethanol concentration (%) | X1 | 40 | 60 | 80 |
| Extraction time (min) | X2 | 30 | 40 | 50 |
| Liquid/solid ratio (mL/g) | X3 | 20:1 | 30:1 | 40:1 |
Levels of independent variables for the Ori liposomes preparation.
| Independent Variables | Code | −1 | 0 | 1 |
|---|---|---|---|---|
| Ultrasonic time (min) | X1 | 20 | 40 | 60 |
| Soybean phospholipids/drug ratio (g/g) | X2 | 6:1 | 8:1 | 10:1 |
| Temperature of water bath (°C) | X3 | 40 | 50 | 60 |
Figure 1The influence of different factors on the extraction yield of Ori. (a) Effect of ethanol concentration on the yield of Ori, (b) Effect of extraction time on the yield of Ori, (c) Effect of liquid/solid ratio on the yield of Ori.
BBD matrix and response values for the extraction yield of Ori.
| Ethanol Concentration | Extraction Time (min) | Liquid/Solid | Ori Yield (mg/g) | ||
|---|---|---|---|---|---|
| Experimental | Predicted | ||||
| 1 | 0 | −1 | 1 | 3.96 | 3.94 |
| 2 | 0 | 0 | 0 | 4.11 | 4.11 |
| 3 | −1 | 1 | 0 | 3.56 | 3.58 |
| 4 | 0 | 0 | 0 | 4.11 | 4.11 |
| 5 | −1 | 0 | 1 | 3.42 | 3.36 |
| 6 | −1 | −1 | 0 | 3.31 | 3.4 |
| 7 | 1 | 1 | 0 | 3.89 | 3.8 |
| 8 | 0 | 1 | −1 | 3.81 | 3.83 |
| 9 | 0 | 1 | 1 | 3.73 | 3.76 |
| 10 | 0 | −1 | −1 | 3.90 | 3.87 |
| 11 | 0 | 0 | 0 | 4.11 | 4.11 |
| 12 | 1 | −1 | 0 | 4.23 | 4.21 |
| 13 | 0 | 0 | 0 | 4.11 | 4.11 |
| 14 | 1 | 0 | 1 | 4.15 | 4.21 |
| 15 | −1 | 0 | −1 | 3.75 | 3.7 |
| 16 | 1 | 0 | −1 | 3.82 | 3.88 |
| 17 | 0 | 0 | 0 | 4.11 | 4.11 |
Figure 23D response surface plots of independent variables in extraction yield of Ori: (a) Effects of ethanol concentration and extraction time on the yield of Ori; (b) Effects of ethanol concentration and Liquid/solid ratio on the yield of Ori; (c) Effects of etraction time and Liquid/solid ratio on the yield of Ori.
BBD design and experimental encapsulation efficiency (%).
| Ultrasonic Time | Soybean Phospholipids/Drug | Temperature of | EE (%) | ||
|---|---|---|---|---|---|
| Experimental | Predicted | ||||
| 1 | 0 | 0 | 0 | 83.89 | 82.66 |
| 2 | −1 | 0 | −1 | 63.14 | 62.67 |
| 3 | 0 | 1 | −1 | 70.13 | 72.15 |
| 4 | 1 | 0 | 1 | 73.62 | 74.09 |
| 5 | 0 | 0 | 0 | 81.92 | 82.66 |
| 6 | 1 | 1 | 0 | 79.52 | 77.53 |
| 7 | −1 | −1 | 0 | 60.95 | 62.94 |
| 8 | −1 | 0 | 1 | 66.63 | 66.66 |
| 9 | 1 | 0 | −1 | 69.91 | 69.88 |
| 10 | 0 | 0 | 0 | 83.67 | 82.66 |
| 11 | 0 | −1 | 1 | 71 | 68.98 |
| 12 | 0 | −1 | −1 | 70.56 | 69.03 |
| 13 | −1 | 1 | 0 | 77.34 | 75.78 |
| 14 | 0 | 0 | 0 | 80.61 | 82.66 |
| 15 | 0 | 0 | 0 | 83.23 | 82.66 |
| 16 | 1 | −1 | 0 | 74.28 | 75.84 |
| 17 | 0 | 1 | 1 | 78.87 | 80.4 |
Results of ANOVA analysis.
| Effects | Source | Sum of Squares | Degree of Freedom (DF) | Mean Square | ||
|---|---|---|---|---|---|---|
| model | 802.47 | 9 | 89.16 | 18.55 | 0.0004 a | |
| Linear | X1 | 107.09 | 1 | 107.09 | 22.28 | 0.0022 a |
| X2 | 105.63 | 105.63 | 21.97 | 0.0022 a | ||
| X3 | 33.54 | 33.54 | 6.98 | 0.0334 a | ||
| Interaction | X1X2 | 31.08 | 31.08 | 6.47 | 0.0385 a | |
| X1X3 | 0.0121 | 0.0121 | 0.0025 | 0.9614 b | ||
| X2X3 | 17.22 | 17.22 | 3.58 | 0.1003 b | ||
| Quadratic | X12 | 205.04 | 205.04 | 42.65 | 0.0003 a | |
| X22 | 29.86 | 29.86 | 6.21 | 0.0414 a | ||
| X32 | 228.13 | 1 | 228.13 | 47.46 | 0.0002 a | |
| Residual | 33.65 | 7 | 4.81 | |||
| Lack of fit | 26.04 | 3 | 8.68 | 4.56 | 0.0883 b | |
| Pure error | 7.61 | 4 | 1.90 | |||
| Cor. total | 836.12 | 16 |
R2 = 0.9598, adjusted R2 = 0.9098 C.V.% = 2.94%. a 5% significance level. b Not significant relative to the pure error.
Figure 33D response surface of independent variables in EE of Ori liposomes: (a) Effects of ultrasonic time and soybean phospholipids/drug on the EE; (b) Effects of soybean phospholipids/drug and temperature of water bath on the EE; (c) Effects of soybean phospholipids/drug and temperature of water bath on the EE.
Figure 4Transmission Electron Microscope (TEM) image and size distribution of Ori-liposomes.
Figure 5Cell survival curves after treating MCF-7cells with different concentrations of blank liposomes, free Ori, and Ori liposomes for 24 h. * p < 0.05, ** p < 0.01.
Figure 6Cellular uptake of C6 and C6-liposomes into MCF-7 cells: (a) Microscopy images of MCF-7 cells treated with different concentrations C6-liposomes for 4 h; (b) Fluorescent intensity of C6 and C6-liposomes in MCF-7 cells after incubation for 4 h. ** p < 0.01.